Research and Markets has announced the addition of the "Global Hemophilia Partnering 2010 to 2016" report to their offering.
Global Hemophilia Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.
Key Topics Covered:
Executive Summary
1 Therapy partnering trends in numbers
- By year
- Most active
- By industry sector
- By deal type
- By technology type
- By stage of development
2 Most active dealmakers
3 Partnering deals directory
- By company A-Z
- By deal value
- By industry sector
- By deal type
- By stage of development
- By technology area
4 Partnering deals with a contract document
5 M&A in numbers
- M&A in numbers - by year
6 M&A deals directory
- M&A deals directory - by company A-Z
- M&A deals directory - by deal value
7 Financing in numbers
- By year
- By financing type
8 Financing deals directory
- By company A-Z
- By deal value
-
By financing type
For more information about this report visit http://www.researchandmarkets.com/research/vtt242/global_hemophilia.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161207005810/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Hematology
